Andrew Thomas Tracey, MD

Memorial Sloan Kettering Cancer Center

Andrew T. Tracey is a current Urologic Oncology fellow at Memorial Sloan Kettering Cancer Center in New York, NY. His clinical interest is in the surgical management of urologic malignancies. He is actively conducting research focused on focal ablative therapies for prostate and upper tract urothelial carcinoma, as well as the genomic characterization of UTUC. After obatining a bachelors degree from the University of Virginia, he obtained a Masters degree in cell biology from Tulane University. For medical school, he attended Rutgers University - New Jersey Medical School and then completed his urology training at Virginia Commonwealth University in Richmond, Virginia.

Presentation(s):

• MP80-08: ADOPTION OF AUA FOLLOW UP GUIDELINES AFTER PARTIAL NEPHRECTOMY ASSOCIATED WITH DECREASED OBSERVED METASTASES BUT NO IMPACT ON SURVIVAL

  Friday, May 15, 2020
  7:00 AM – 9:00 AM

• MP82-02: SURVIVAL IMPACT OF VARIANT HISTOLOGY DIAGNOSIS IN UPPER TRACT UROTHELIAL CARCINOMA

  Friday, May 15, 2020
  7:00 AM – 9:00 AM

• PD18-10: Identifying the frequency of actionable genomic alterations in localized and metastatic upper tract urothelial carcinoma

  Friday, May 15, 2020
  7:00 AM – 9:00 AM